SEARCH HEALTH CONDITIONS BY ALPHABETS
Giant Cell Tumor of Bone
Medications for Giant Cell Tumor of Bone
Other names: GCTB
About Giant Cell Tumor of Bone: Giant cell tumor of bone (GCTB) is a fairly rare, benign but locally aggressive osteolytic skeletal neoplasm of young adults
Drugs Used to Treat Giant Cell Tumor of Bone
This listing of medications have been somehow related to, or found at the treating this condition.
Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Xgeva | Rx | X | N | 2 testimonials | 9.0 | ||
Generic title: denosumab systemic Drug class: amalgamated bone resorption inhibitors For users: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
denosumab | Rx | X | N | 3 testimonials | 7.7 | ||
Generic title: denosumab systemic Brand title: Xgeva Drug class: amalgamated bone resorption inhibitors For users: dosage, interactions, For professionals: az Medication Truth, AHFS DI Monograph | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | On The Counter |
Rx/OTC | Prescription or Over the Counter |
Off Label | This drug may well not be approved by the FDA for the treatment of the condition. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to present a risk to the fetus within the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
C | Animal reproduction studies have demonstrated a negative effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in elderly women clearly outweigh potential rewards. |
N | FDA have not classified the medication. |
Controlled Substances Act (CSA) Program | |
---|---|
N | isn`t at the mercy of the Controlled Substances Act. |
Inch | includes a high potential for misuse. Has no currently accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
2 | includes a high potential for misuse. Includes a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Psychotherapy can result in severe emotional or physical dependency. |
3 | Has a possibility for abuse less than individuals in schedules 1 and 2 two. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence. |
4 | includes a minimal potential for abuse in accordance with individuals in program 3. It has a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to individuals in program 3. |
5 | includes a minimal potential for abuse in accordance with individuals in program 4. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence. |
Infection | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always ask your physician to make sure the information relates to your circumstances.
Product Categories